Large-scale testing (Phase 3)Study completedNCT03405935
What this trial is testing
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years
Who this might be right for
HIV-1 Infection
Gilead Sciences 86